Page 238 - Read Online
P. 238
Page 8 of 8 Lee et al. Hepatoma Res 2020;6:21 I http://dx.doi.org/10.20517/2394-5079.2019.44
76. Yang JD, Aqel BA, Pungpapong S, Gores GJ, Roberts LR, et al. Direct acting antiviral therapy and tumor recurrence after liver
transplantation for hepatitis C-associated hepatocellular carcinoma. J Hepatol 2016;65:856-68.
77. Bigam D, Shapiro AMJ, Kneteman N. HCV eradication with direct-acting antivirals does not impact HCC progression on the waiting
list or HCC recurrence after liver transplantation. Can J Gastroenterol Hepatol 2019;2019:2509059.
